Atlas Trials

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

Clinical trial NCT05588297 · UNKNOWN

Trial details

NCT number
NCT05588297
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Liver Metastases
Start date
2022-10-01
Primary completion
2023-03-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.